Skip to main content
Log in

Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells

  • Preclinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Abstract

The cytotoxic activity of various chemotherapy agents was investigated in asynchronous populations of cultured 9L rat brain tumor cells, and as a function of their position in the cell cycle. Representative drugs from the classes of DNA-active agents, alkylating agents, spindle poisons, and antimetabolites were tested. The ability to induce cell lethality in asynchronous populations as a function of drug concentration varied for 1 hr pulse exposures. In order of decreasing cytotoxic activity, DHAQ was the most effective, followed by VCR, VDS, VBL, ADR, BCNU, cis-DDP, BLM, DBD, RZ, and HU. The effect of chemotherapy agents on synchronous 9L cells obtained by mitotic selection also varied with respect to the individual agent and was cell cycle-dependent. Survival age-responses ranged from being minimal to demonstrating significant fluctuations as a function of cell cycle position. For all agents except ADR and HU, the sensitivity of G1 phase was greater than S phase. RZ exhibited essentially a flat age-response. Comparison of the cell cycle age-responses of chemotherapeutic agents to those exhibited by the cytotoxic modalities of radiation and hyperthermia demonstrate several unique differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ADR:

Adriamycin

BCNU:

1,3-Bis (2-Chloroethyl)-1-Nitrosourea

BLM:

Bleomycin sulfate

cis-DDP:

cis-Dichlorodiamineplatinum

DHAQ:

Dihydroxy anthraquinone

DBD:

Dibromodulcitol

HU:

Hydroxyurea

RZ:

Razoxane

VBL:

Vinblastine Sulfate

VCR:

Vincristine Sulfate

VDS:

Vindesine Sulfate

HBSS:

Hanks' Balanced Salt Solution

References

  1. Drewinko B, Barlogie B: The relevance of cell kinetics in determining drug activity in vitro. In: C Nicolini (ed) Cell Growth. Plenum Press: New York, pp 749–772, 1982

    Google Scholar 

  2. Valeriote FA: The use of cell kinetics in the development of drug combinations. Pharm Ther 4:1–33, 1979

    Google Scholar 

  3. Wheeler KT, Tel N, Williams ME, Sheppard S, Levin VA, Kabra PM: Factors influencing the survival of rat brain tumor cells following in vitro treatment with 1,3-bis (2chloroethyl)-1-nitrosourea. Cancer Res 35:1464–1469, 1975

    Google Scholar 

  4. Nomura K, Hoshino T, Knebel K, Deen DF, Barker M: BCNU-induced perturbations in the cell cycle of 9L rat brain tumor cells. Cancer Treat Rep 62:747–754, 1978

    Google Scholar 

  5. Hoshino T, Wilson CB: Cell kinetic analysis of human malignant brain tumors (gliomas). Cancer 44:6956–6962, 1979

    Google Scholar 

  6. Marton LJ, Levin VA, Hervatin SJ, Kock-Wesser J, McCann PP, Sjoerdsma A: Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by α-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 41:4426–4431, 1981

    Google Scholar 

  7. Hoshino T, Deen DF, Williams MR, Sano Y: Differential response of elutriated 9L cells to treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea. Cancer Res 41:4404–4407, 1981

    Google Scholar 

  8. Bjerkvig R, Oredsson SM, Marton LJ, Linden M, Deen DF: Cel cycle age responses of 9L cells to 1,3-bis(2-chloro ethyl)-1-nitrosourea and modification by α-difluoromethyl ornithine. Cancer Res 43:1497–1500, 1983

    Google Scholar 

  9. Nomura K, Hoshino T, Deen DF, Knebel KD: Perturbed cell kinetics of 9L rat brain tumor cells following dianhydrogalactitol. Cancer Treat Rep 62:2055–2061, 1978

    Google Scholar 

  10. Deen DF, Hoshino T, Williams ME, Nomura K, Bartle PM: Response of 9L tumor cells in vitro to spirohydantoin mustard. Cancer Res 39:4336–4340, 1979

    Google Scholar 

  11. Oredsson SM, Deen DF, Marton LJ: Decreased cytotoxicity of cis-diammine-dichloroplatinum (II) by α-difluoro-methylornithine depletion of polyamines in 9L rat brain tumor cells in vitro. Cancer Res 42:1296–1299, 1982

    Google Scholar 

  12. Keng PC, Wheeler KT:Radiation response of synchronized 9L rat brain tumor cells separated by centrifugal elutriation. Radiat Res 83:633–643, 1980

    Google Scholar 

  13. Kimler BF, Henderson SD: Cyclic responses of cultured 9L cells to radiation. Radiat Res 91:155–168, 1982

    Google Scholar 

  14. Zar JH: Biostatistical Analysis, pp. 198–235. Englewood Cliffs, NJ: Prentice-Hall, Inc 1974

    Google Scholar 

  15. Kimler BF, Cheng CC: Comparison of the effects of dihydroxyanthraquinone and Adriamycin on the survival of cultured Chinese hamster cells. Cancer Res 42:3631–3636, 1982

    Google Scholar 

  16. Umezawa H, Ishizuka M, Maeda K, Takeuchi T: Studies on bleomycin. Cancer 20:891–895, 1967

    Google Scholar 

  17. Burger RM, Peisach J, Horwitz SB: Mechanisms of bleomycin action: in vitro studies. Life Science 28:715–727, 1981

    Google Scholar 

  18. Henderson SD, Kimler BF, Scanlon MF: Interaction of hyperthermia and radiation on the survival of synchronous 9L cells. Radiat Res 92:146–159, 1982

    Google Scholar 

  19. Henderson SD, Kimler BF: Response of cultured 9L cells to bleomycin and X-rays. (Abstract) Radiat Res 83:371, 1980

    Google Scholar 

  20. Twentyman PR: Bleomycin — mode of action with particular reference to the cell cycle. Pharmac Ther 23:417–441, 1984

    Google Scholar 

  21. Gridna DJ, Sigdestad CP, Peters LJ: Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells. Br J Cancer 42:677–683, 1980

    Google Scholar 

  22. Barranco SC: Cellular and molecular effects of adriamycin on dividing and nondividing cells. Pharmac Ther 24:303–319, 1984

    Google Scholar 

  23. Meyn R, Murray D: Cell cycle effects of alkylating agents. Pharmac Ther 24:147–163, 1984

    Google Scholar 

  24. Drewinko B, Gottlieb JA: Action of cis-dichlorodiammine-platinum (II) (NSC 119875) at the cellular level. Cancer Chemother Rep 59:655–673, 1975

    Google Scholar 

  25. Kimler BF: Interaction of razoxane and radiation on cultured Chinese hamster cells. Int J Radiat Oncol Biol Phys 8:1333–1338, 1982

    Google Scholar 

  26. Traganos F, Evenson DP, Staino-Coico L, Darzynkiewicz F, Melamed MR: Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells. Cancer Res 40:671–681, 1980

    Google Scholar 

  27. Madoc-Jones H, Mauro F: Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J-Cell Physiol 72:185–196, 1968

    Google Scholar 

  28. Olah E, Polyi I, Sugar J: Effects of cytostatics on proliferating and stationary cultures of mammalian cells. Eur J Cancer 14:895–900, 1978

    Google Scholar 

  29. Wibe E: Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one. Cancer Res 40:2069–2073, 1980

    Google Scholar 

  30. Sinclair WK: Hydroxyurea: Differential lethal effects on cultured mammalian cells during the cell cycle. Science 150:1729–1731, 1965

    Google Scholar 

  31. Kim JH, Gelbind AS, Perez AG: Action of hydroxyurea on the nucleic acid metabolism and viability of HeLa cells. Cancer Res 27:1301–1305, 1967

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henderson, S.D., Kimler, B.F. & Barnes, M.L. Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells. Invest New Drugs 5, 145–154 (1987). https://doi.org/10.1007/BF00203539

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00203539

Key words

Navigation